Literature DB >> 20877927

[Health research: making easier the appropriation of scientific knowledge in health management].

.   

Abstract

Mesh：

Year:  2010        PMID： 20877927     DOI： 10.1590/s0034-89102010000500024

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN： 0034-8910            Impact factor:   2.106


× No keyword cloud information.
  1 in total

1.  Cost-effectiveness analysis of XELOX versus XELOX plus bevacizumab for metastatic colorectal cancer in a public hospital school.

Authors:  Andrea Queiróz Ungari; Leonardo Régis Leira Pereira; Altacílio Aparecido Nunes; Fernanda Maris Peria
Journal:  BMC Cancer       Date:  2017-10-17       Impact factor: 4.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.